Back to search

Article

A multiplexed Cas13-based assay with point-of-care attributes for simultaneous COVID-19 diagnosis and variant surveillance

2022-03-18

Abstract excerpt

Point-of-care (POC) nucleic acid detection technologies are poised to aid gold-standard technologies in controlling the COVID-19 pandemic, yet shortcomings in the capability to perform critically needed complex detection—such as multiplexed detection for viral variant surveillance—may limit their widespread adoption. Herein, we developed a robust multiplexed CRISPR-based detection using LwaCas13a and PsmCas13b to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54f45234-e207-56c6-8bcf-c99496891d7d
DOI
10.1101/2022.03.17.22272589
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A multiplexed Cas13-based assay with point-of-care attributes for simultaneous COVID-19 diagnosis and variant surveillanceDOI 10.1101/2022.03.17.22272589
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant SurveillanceSemantic proximity
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19Semantic proximity
Next-Generation Nucleic Acid-Based Diagnostics for Viral Pathogens: Lessons Learned from the SARS-CoV-2 PandemicSemantic proximity
Digital CRISPR/Cas‐Assisted Assay for Rapid and Sensitive Detection of SARS‐CoV‐2Semantic proximity
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care DiagnosticsSemantic proximity
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and TherapeuticsSemantic proximity
Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assaySemantic proximity
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.Semantic proximity
Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variantsSemantic proximity
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 EnzymeSemantic proximity
From Lab to Life: The Rise of CRISPR-Based Diagnostics for Point-of-Care and Global HealthSemantic proximity
An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing.Semantic proximity
Select a neighboring publication to make it the new centre.